Last week, Dublin biotechnology company Nuritas announced a $45 million funding round to help accelerate its global expansion, bring its total funding to date to a hefty $75 million. The Series B round was led by Chicago-based Cleveland Avenue, the food investor fund led by Don Thompson, the former president and CEO of McDonald’s Corporation. The company said other backers included Grosvenor’s Wheatsheaf Group, the European Circular Bioeconomy Fund (ECBF), Vertex Holdings, Nutresa Ventures/Veronorte and CJ. However, it has now emerged that a number of the company’s early investors – including three members of U2 and also the state agency…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .